Alter, M.J., Kuhnert, W.L., Finelli, L. (2003, February 8). Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMMR: Morbidity & Mortality Weekly Report 52 (RR-3).
American Red Cross. (2004). Maximizing Blood Safety for Patients. Retrieved Sept. 6, 2005 from http://chapters.redcross.org/ca/norcal/donating/max.htm
Carey, W.D., Lenox, J. (2004). Hepatitis C Management. The Cleveland Clinic. Retrieved June 19, 2005, from http://www.clevelandclinicmeded.com/hcv/default.htm
Centers for Disease Control
and Prevention. (1998). MMMR: Morbidity & Mortality Weekly Report. 47
Centers for Disease Control and Prevention. (2003). Living with Chronic Hepatitis C.
Centers for Disease Control & Prevention. (2003, January 24). Prevention & control of infections with hepatitis viruses in correctional settings. MMWR: Morbidity & Mortality Weekly Report.
Centers for Disease Control & Prevention. (2003, April 4). MMWR: Morbidity and Mortality Weekly Report 52(13): 273-4, 276. Hepatitis C virus transmission from an antibody-negative organ and tissue donor-United States, 2000-2002.
Center for Disease Control and Prevention. Viral Hepatitis C. Fact Sheet. (2005) Retrieved September 6, 2005, from http://www.cdc.gov/ncidod/diseases/hepatitis/c/fact.htm
Centers for Disease Control & Prevention. (2005). Viral hepatitis C. Retrieved June 19, 2005, from http://www.cdc.gov/ncidod/diseases/hepatitis/c/plan/HCV_infection.htm
Centers for Disease Control and Prevention
Hepatitis C FAQs for Health Professionals (2014)
Management and Treatment
Accessed online 11/23/14
Chander, G. Sulkoski, M.S., Jenckes, M.W. et al. (2002, November). Treatment of chronic hepatitis C: A systematic review. Hepatology 36: S135-S144.
Epidemic.Org. (1998). Hepatitis C. Retrieved June 20, 2005, from http://www.epidemic.org/index2.html
Finelli, L., Miller, J.T., Tokars, J.I., et al. (2002). National surveillance of dialysis-associated diseases in the United States, 2002. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
Fong, Tse-Ling. (2002, April 17). Hepatocellular carcinoma. Medicine Net.com. Retrieved June 19, 2005, from http://www.medicinenet.com/liver_cancer/article.htm
Gebo, K.A., Chander, G., Jenckes, M.W. et al. (2002, November). Screening tests for hepatocellular carcinoma in patients with hepatitis C: A systemic review. Hepatology 36: S84-S92.
Ghany, M.; Strader, D. et al., (2009) Diagnosis, Management, and Treatment of Hepatitis C: An Update. Hepatology. 2009 April;49(4);1335-74
Hughes, J.M. (1998, October 16). Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease.
Lutwick, L.I. (2001). Hepatitis C.The Gale Encyclopedia of Medicine. Second Edition. Longe, J.L., Ed. 5 vols. Farmington Hills, MI: Gale Group.
Maynard, M., Pradat, P, Berthillon, G. et al. (2003, September 29). Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and predicting patients' response to therapy. Journal of Viral Hepatitis. Retrieved June 17, 2005, from http://www.medscape.com/viewarticle/460553
MedicineNet.com. (2005). Hepatitis C Index. Retrieved June 17, 2005, from http://www.medicinenet.com/hepatitis_c/index.htm
Medical News Today. (2005, June 10). How hepatitis C virus invades immune system in acute and chronic infections. Retrieved June 20, 2005, from http://www.medicalnewstoday.com/medicalnews.php?newsid=25898
National Digestive Disease
Information Clearinghouse. National Institiute of Diabetes and Kidney Disease.
(2003). Chronic Hepatitis C: Current Disease
Management. Retrieved Sept. 6, 2005
Nguyen, M.H., & Keefe, E.B. (2004)Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9. Reviews in Gastroenterological Disorders 514 (4): Supplement 514-521.
Northwest Tissue Center. (2005, Winter). NAT and tissue banking: The time has come. Retrieved June 18, 2005, from http://www.nwtc.org/resource/2005_winter/06.htm
Pavio, N; Lai, M (2003) The hepatitis C virus persistence: how to evade the immune system?
Journal of Bioscience Vol. 28 | No. 3 | April 2003 | 287–304
Razavi, H; Elkhoury, A; Elbasha, E; et al. (2013)
Chronic Hepatitis C Virus (HCV) Disease Burden and Cost in the United States
HEPATOLOGY, June 2013
American Association for the Study of Liver Diseases.
Rebetron. (2003, October).[ Product information insert.] Kenilworth, N.J.: Schering Corporation.
Reddy, K.R. (2002, April 29). Public-health impact, natural history, diagnosis, & clinical management of hepatitis C: Emerging clinical options with interferon-based therapies. Medscape. Retrieved June 19, 2005, from http://www.medscape.com/viewprogram/1809
Ribivarin. (2004, July 13). AIDS Treatment Data Network. Retrieved June 19, 2005, from http://www.atdn.org/simple/riba.html
Rifai, M.A., & Rosenstein, D.L. (2005). Hepatitis C and psychiatry. Focus 3: 194-202.
Schaffner, F., & Punch, J. (2003). Hepatitis C and liver transplantation. TransWeb, University of Michigan. Retrieved June 18, 2005, from http://www.transweb.org/qa/qa_txp/faq_hepatitisc.html
Swartz, A. (2002, September,
October). Hepatitis C Co-infection: A dangerous trend. HIV Impact: 11.
Hepatitis C: Index: (2005, June 19). Hepatitis C Information Center. Retrieved June 19, 2005, from http://hepatitis-central.com/hcv/
Swinker, M. (1997). American Family Physician. Retrieved June 17, 2005, from http://www.aafp.org/afp/971200ap/swinker.html
Transplant News 9 (13). (1999). Hepatitis C positive livers transplanted in HCV-infected patients work well.
Transplant News 9 (18). (1999). CDC reports at least 3 million chronically infected with hepatitis C.
Transplant News 9 (23). (1999). Hepatitis C patients with a history of alcoholism can still receive liver transplants, study finds.
Transplant News 13 (17): 0. (2003). Hepatitis C recurrence after liver transplant generally mild, study finds.
Transplant News 13 (20): 0. (2003). Risk of HCV-infected allografts serious public health threat.
U.S. Dept. of Veterans Affair
Update on the Management and Treatment of Hepatitis C Virus Infection: Recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office
Accessed online 11/19/14
Warren, Jim. (2004, September 30). Beating FDA to the punch, AATB requires accredited tissue banks to implement NAT testing for HIV-1, HCV. (Federal Drug Administration; American Association of Tissue Banks; nucleic acid testing for HIV-1 and hepatitis C virus). Transplant News 14 (18):0
WHO. Fact Sheet 164: Hepatitis C. (2000, October). Retrieved June 19, 2005, from http://www.who.int/mediacentre/factsheets/fs164/en/
Worman, H. J. (2002). Hepatitis B. Columbia University Medical Center. Retrieved June 19, 2005, from http://cpmcnet.columbia.edu/dept/gi/hepB.html
Yovtcheva, S.P., Rifai, M.A., Moles, J.K., & Van Der Linden, B.J. (2005). Psychiatric comorbidity among hepatitis C positive patients. Focus 3: 261-265.